Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
55199801000001116 | Bismuth subsalicylate 262.5mg chewable tablets sugar free (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
55199901000001110 | Bismuth subsalicylate 262.5mg chewable tablets sugar free | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Pepto-Bismol 262.5mg chewable tablets (Procter & Gamble (Health & Beauty Care) Ltd) | Is a | True | Bismuth subsalicylate 262.5mg chewable tablets sugar free | Inferred relationship | Existential restriction modifier | |
Bismuth subsalicylate 262.5mg chewable tablets sugar free 12 tablet | Has VMP | True | Bismuth subsalicylate 262.5mg chewable tablets sugar free | Inferred relationship | Existential restriction modifier | |
Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet | Has VMP | True | Bismuth subsalicylate 262.5mg chewable tablets sugar free | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets